# Oncospace, Inc.

- Location (FDA's records): Baltimore, MD
- FDA decisions: 3 (2021–2025): 3 510(k) clearances
- Product codes: MUJ (3)
- 510(k) review time since 2016: median 211 days, against 140 for FDA's reviews in the same codes and years (1 of 3 faster)
- Predicates its devices cite: 3 (2 its own); citations of its devices by later devices: 4 (2 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Brainlab AG: 1 (https://510kreport.com/company/brainlab)

## Firms that cite its devices most
- Mvision AI OY: 1 (https://510kreport.com/company/mvision-ai)
- Informai: 1 (https://510kreport.com/company/informai)

## Its most-cited devices
- K222803: Oncospace (2023), cited by 3
- K202284: Oncospace (2021), cited by 1

## Recent decisions
- K242748: Oncospace (Apr 11, 2025)
- K222803: Oncospace (Feb 2, 2023)
- K202284: Oncospace (Mar 12, 2021)

Source page: https://510kreport.com/company/oncospace